About Us

Chairman's Greeting

Keeping Up with Science

The past few months were a most exciting period for both the Macular Degeneration Association (MDA) and macular degeneration scientific research. To call it revolutionary would be putting it mildly.

Until recently, no test existed to help determine patients’ inherited risk for AMD. Macula Risk® (ArcticDX, Toronto, Ontario) is a genetic test specifically designed to determine genetic predisposition to AMD and vision loss attributed to the more advanced stage of the disease. This test provides a genetic profile screening to help identify those at risk and aids in tailoring a distinct management approach for those already diagnosed with AMD.

Here at MDA, we are committed to keeping up with science.

In light of such a huge advancement in the treatment of AMD, we knew MDA needed to make the genetic test a key component of our patient education program. MDA’s recent partnership with Eye Solutions makes the genetic test now available to seniors at any of our MDA patient education events.

By aligning ourselves with researchers at the frontier of macular science, we are able to serve a much greater portion of the population. Now, we not only serve diagnosed macular patients, but we are able to help the general population at large discover their individual risk of developing AMD. 

Sincerely,

Lawrence S. Hoffheimer

Chairman